Nephrol Dial Transplant (2000) 15: 1919-1921
© 2000 European Renal Association-European Dialysis and Transplant Association
Editorial Comments
Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease?
CNR Centro Fisiologia Clinica and Divisione di Nefrologia Ospedali Riuniti, Reggio Cal, Italy
Epidemiology of sleep apnoea in the general population and in dialysis patients
Estimates of the prevalence of sleep apnoea syndrome (SA) in the general population give widely different figures, ranging from 0.3 to 8.5% [13]. This is probably because of differences in definitions, in the design of the studies and the investigations performed as well as in the age, sex and other characteristics of the populations surveyed. The prevalence of this disturbance in patients on chronic dialysis is still uncertain but available estimates indicate that it may be at least five times higher than that in the general population [48]. Snoring is the symptom that usually alerts the physician to suspect SA. Restless sleep, frequent arousal, daytime somnolence, headaches and fatigue are all common complaints of patients with SA which may be mistakenly attributed to chronic renal failure. Perhaps the main reason why SA
Why is SA so frequent in dialysis patients?
SA and cardiovascular risk in renal failure
Why are SA and nocturnal hypoxaemia in dialysis patients so often overlooked?
Notes
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Chakravorty, M. Shastry, and K. Farrington Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment Nephrol. Dial. Transplant., January 1, 2007; 22(1): 28 - 31. [Full Text] [PDF] |
||||
![]() |
C. Zoccali, F. Mallamaci, and G. Tripepi Nocturnal Hypoxemia Predicts Incident Cardiovascular Complications in Dialysis Patients J. Am. Soc. Nephrol., March 1, 2002; 13(3): 729 - 733. [Abstract] [Full Text] [PDF] |
||||

